RETINALGENIX TECHNOLOGIES INC. Stock or Unit Option Plan Expense
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Stock or Unit Option Plan Expense of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2026-08-14
- RETINALGENIX TECHNOLOGIES INC. stock or unit option plan expense for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- RETINALGENIX TECHNOLOGIES INC. stock or unit option plan expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- RETINALGENIX TECHNOLOGIES INC. stock or unit option plan expense for the quarter ending 2025-06-30 was $23.45K, a 98.67% decline year-over-year.
- RETINALGENIX TECHNOLOGIES INC. stock or unit option plan expense for the quarter ending 2025-03-31 was $23.46K, a 87.25% decline year-over-year.
- RETINALGENIX TECHNOLOGIES INC. stock or unit option plan expense for fiscal 2025 was $54.73K, a 86.04% decline from fiscal 2024.
- RETINALGENIX TECHNOLOGIES INC. stock or unit option plan expense for fiscal 2024 was $391.95K, a 40.99% decline from fiscal 2023.
- RETINALGENIX TECHNOLOGIES INC. stock or unit option plan expense for fiscal 2023 was $664.21K.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-20 | |||
| 2025-12-31 | $54.73K 10-K · filed 2026-04-15 | |||
| 2025-06-30 | $23.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $46.91K 10-Q · filed 2026-08-14 | $97.89K derived: sum of 3 quarters · filed 2026-08-14 | $176.40K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $23.46K 10-Q · filed 2026-05-20 | $74.44K derived: sum of 2 quarters · filed 2026-05-20 | $152.95K derived: sum of 3 quarters · filed 2026-05-20 | $1.91M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $50.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $129.49K derived: sum of 2 quarters · filed 2026-04-15 | $1.89M derived: sum of 3 quarters · filed 2026-04-15 | $391.95K 10-K · filed 2026-04-15 |
| 2024-09-30 | $78.51K 10-Q · filed 2024-11-18 | $1.84M derived: sum of 2 quarters · filed 2024-11-18 | $340.97K 10-Q · filed 2024-11-18 | $2.10M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $1.94M 10-Q · filed 2024-08-19 | $2.02M derived: sum of 3 quarters · filed 2025-05-15 | $2.45M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $183.95K 10-Q · filed 2025-05-15 | $262.46K derived: sum of 2 quarters · filed 2025-05-15 | $691.14K derived: sum of 3 quarters · filed 2025-05-15 | $769.65K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $78.51K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $507.19K derived: sum of 2 quarters · filed 2025-03-31 | $585.70K derived: sum of 3 quarters · filed 2025-03-31 | $664.21K 10-K · filed 2025-03-31 |
| 2023-09-30 | $428.68K 10-Q · filed 2024-11-18 | $507.19K derived: sum of 2 quarters · filed 2024-11-18 | $585.70K 10-Q · filed 2024-11-18 | |
| 2023-06-30 | $78.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $157.02K 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | $78.51K 10-Q · filed 2024-05-20 |